Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,858 | 9,880 | 11,246 | 5,310 | 3,734 |
| Depreciation Amortization | 672 | 2,520 | 1,825 | 1,176 | 535 |
| Income taxes - deferred | -738 | -1,109 | -1,022 | -491 | -191 |
| Accounts receivable | 8,573 | -10,806 | -5,981 | -4,966 | -722 |
| Accounts payable and accrued liabilities | 139 | 13 | 446 | -37 | 14 |
| Other Working Capital | 9,514 | -15,554 | -6,088 | -3,635 | -3,346 |
| Other Operating Activity | -5,122 | 16,066 | 6,209 | 4,602 | -153 |
| Operating Cash Flow | $3,180 | $1,010 | $6,635 | $1,959 | $-129 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -564 | N/A | N/A |
| PPE Investments | -172 | -1,160 | -1,027 | -359 | -121 |
| Purchase Of Investment | -12,951 | -14,010 | -11,184 | -11,184 | -8,403 |
| Sale Of Investment | 10,073 | 15,429 | 11,190 | 11,190 | 11,190 |
| Purchase Sale Intangibles | -5 | -733 | -737 | -722 | -699 |
| Other Investing Activity | -5 | -733 | -737 | -722 | -699 |
| Investing Cash Flow | $-3,055 | $-474 | $-2,322 | $-1,075 | $1,967 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | 25,865 | 25,547 | 25,497 | 1,465 |
| Other Financing Activity | 0 | -1,487 | -1,487 | -1,802 | -121 |
| Financing Cash Flow | $21 | $24,378 | $24,060 | $23,695 | $1,344 |
| Exchange Rate Effect | 285 | 343 | 216 | 99 | 50 |
| Beginning Cash Position | 37,070 | 11,813 | 11,813 | 11,813 | 11,813 |
| End Cash Position | 37,501 | 37,070 | 40,402 | 36,491 | 15,045 |
| Net Cash Flow | $431 | $25,257 | $28,589 | $24,678 | $3,232 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,180 | 1,010 | 6,635 | 1,959 | -129 |
| Capital Expenditure | -178 | -1,190 | -1,046 | -378 | -122 |
| Free Cash Flow | 3,002 | -180 | 5,589 | 1,581 | -251 |